Table 3.
Comparison of UPCR Between the Two Groups During Treatment
| Group | Baseline | 1 Month | 3 Months | F | P Value |
|---|---|---|---|---|---|
| RASI + Finerenone | 1.22 (0.64, 2.04) | 0.86 (0.45, 1.83) ** | 0.68 (0.34, 1.50) *** | 14.895 | <0.001 |
| RASI | 1.12 (0.65, 2.12) | 0.91 (0.69, 1.84) | 1.04 (0.57, 1.50) | 1.709 | 0.187 |
| U | 0.002 | 4.092 | 6.336 | ||
| P value | 0.804 | 0.453 | 0.163 | ||
| F (Time) =13.527 F (Treatment) = 0.542 F (Time * Treatment) = 3.508 | |||||
| P (Time) < 0.001 P (Treatment) = 0.464 P (Time * Treatment) = 0.032 | |||||
Notes: Data are presented as median (IQR). ** and *** indicate significant differences compared with baseline data (P < 0.01 and P < 0.001, respectively).
Abbreviations: UPCR, Urine protein creatinine ratio; RASI, renin–angiotensin system inhibitor.